LIFECELL CORP. FDA Inspection Record
LIFECELL CORP. is an FDA-registered facility (FEI 1000306051) located in BRANCHBURG, NJ, US. RegDataLab tracks 12 FDA inspections and 3 compliance actions at this facility.
What FDA found at this site
- Latest inspection
- May 21, 2024: No Action Indicated (NAI)
- Inspections on record
- 12 (1 OAI, 2 VAI, 9 NAI)
- Last OAI inspection
- Nov 12, 2010
- Warning letters
- 3 listed by FDA for this FEI, latest Jun 1, 2015
- Recalls as the recalling firm
- 8, latest Dec 2, 2019
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| May 21, 2024 | No Action Indicated (NAI) | No citations listed |
| Feb 20, 2020 | No Action Indicated (NAI) | No citations listed |
| Jun 14, 2019 | Voluntary Action Indicated (VAI) | Procedures not adequately established or maintained (21 CFR 820.40) Lack of or inadequate procedures (21 CFR 820.100(a)) Management review - Lack of or inadequate procedures (21 CFR 820.20(c)) Lack of or inadequate process validation (21 CFR 820.75(a)) |
| Sep 27, 2017 | No Action Indicated (NAI) | No citations listed |
| Aug 25, 2017 | No Action Indicated (NAI) | Procedures not adequately established or maintained (21 CFR 820.40) Lack of or inadequate procedures - Acceptance activities (21 CFR 820.80(a)) Lack of or inadequate procedures (21 CFR 820.100(a)) Documented evaluation (21 CFR 820.50(a)(1)) and 1 more |
| Jun 21, 2016 | No Action Indicated (NAI) | No citations listed |
| May 14, 2015 | No Action Indicated (NAI) | No citations listed |
| Sep 16, 2013 | No Action Indicated (NAI) | No citations listed |
| Feb 1, 2013 | Voluntary Action Indicated (VAI) | Sponsors' general responsibilities (21 CFR 812.40) |
| Aug 15, 2011 | No Action Indicated (NAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Dec 2, 2019 | Class II | B-0478-2020 | Skin - ALLODERM SELECT" Regenerative Tissue Matrix (RTM), Ready To Use product (RH205476… Human bone allografts associated with a failure to prevent distribution of allografts that do not meet release criteria designed to prevent… |
| Aug 8, 2017 | Class II | Z-0823-2018 | REVOLVE ADVANCED ADIPOSE SYSTEM, for aspiration, harvesting, filtering, and transferring… Presence of bacterial endotoxins levels above the acceptable limit |
| May 2, 2008 | Class III | B-1138-08 | AlloDerm Regerative Tissue Matrix, 2x4 cm, .33-76 mm; AlloDerm GBR; 2x2 cm, .46-86 mm… Skin allografts, recovered from a donor who was improperly assessed for hemodilution, were distributed. |
| Oct 17, 2007 | Class III | B-0928-08 | Cryopreserved Allograft Skin, Non-Meshed and Cryopreserved Allograft Skin, Meshed and 9 more products Human tissues from donors, tested using diagnostic test kits rather than FDA licensed or cleared screening tests for hepatitis B surface… |
| Oct 9, 2007 | Class I | B-0909-08 | AlloDerm Regenerative Tissue Matrix
Oral Plastic Surgery
1x2cm, .89-1.65 (mm) and 1x4cm… and 5 more products A reactive (confirmed positive) test result for Hepatitis B Surface Antigen was obtained on a re-test sample from lot B16375, |
| Jul 21, 2006 | Class II | B-0128-7 | Acellular Dermal Matrix Grafts
AlloDerm, Repliform and GraftJacket (91 tissue… Human tissues, collected from a donor who had not been properly evaluated fro hemo-dilution, were distributed. |
| Jan 30, 2006 | Class II | B-1197-6 | Skin Tissue, AlloDerm/Repliform Regenerative Tissue Matrix. Skin Tissue, that was subsequently found to test repeatedly reactive for antibodies to Hepatitis B Core Total (igM/IgG) by a different… |
| Sep 30, 2005 | Class I | B-0276-6 | Acellular Dermal Matrix Skin Tissue Human Tissues, procured from donors without adequate donor eligibility determinations, were distributed. |
FDA record score
4 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
12 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Inspection classified VAI | Jun 14, 2019 | 6 x 0.25 | 1.5 |
| Class II recall B-0478-2020, this FEI as the recalling firm | Dec 2, 2019 | 4 x 0.25 | 1 |
| Class II recall Z-0823-2018, this FEI as the recalling firm | Aug 8, 2017 | 4 x 0.25 | 1 |
| Warning letter on FDA's dashboard, which does not show close-outs | Jun 1, 2015 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Feb 1, 2013 | 10 years or older, so it adds no points | 0 |
| Warning letter on FDA's dashboard, which does not show close-outs | May 6, 2011 | 10 years or older, so it adds no points | 0 |
| Inspection classified OAI | Nov 12, 2010 | 10 years or older, so it adds no points | 0 |
| Warning letter on FDA's dashboard, which does not show close-outs | Oct 10, 2008 | 10 years or older, so it adds no points | 0 |
| Class I recall B-0909-08, this FEI as the recalling firm | Oct 9, 2007 | 10 years or older, so it adds no points | 0 |
| Class II recall B-0128-7, this FEI as the recalling firm | Jul 21, 2006 | 10 years or older, so it adds no points | 0 |
| Class II recall B-1197-6, this FEI as the recalling firm | Jan 30, 2006 | 10 years or older, so it adds no points | 0 |
| Class I recall B-0276-6, this FEI as the recalling firm | Sep 30, 2005 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing LIFECELL CORP. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check LIFECELL CORP. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- LifeCell Corporation
- Location
- BRANCHBURG, NJ (US)
- Source
- device